14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
The U.S. Department of Labor’s Occupational Safety and Health Administration (OSHA) has released gu...
Read More >
As concerns continue regarding the possibility of an economic downturn, plan sponsors should be awar...
Read More >
The Benefit of Knowing- Monday morning quarterbacking – the connotations are anything but positive...
Read More >
The New York state legislature has passed a bill that would allow employees making certain claims fo...
Read More >
I use the expression “garbage in, garbage out” if an end of year census report is done incorrectly...
Read More >
Despite news of additional COVID-19-related deaths and infections in America, central bankers appear...
Read More >